Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients

详细信息    查看全文

• 作者：Junwei Huo ; Jing Hu ; Gaowei Liu ; Yajie Cui…
• 关键词：Interleukin ; 37 ; Epithelial ovarian cancer ; Prognosis ; Biomarker
• 刊名：Archives of Gynecology and Obstetrics
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：295
• 期：2
• 页码：459-465
• 全文大小：
• 刊物类别：Medicine
• 刊物主题：Gynecology; Obstetrics/Perinatology; Endocrinology; Human Genetics;
• 出版者：Springer Berlin Heidelberg
• ISSN：1432-0711
• 卷排序：295

文摘

PurposeInterleukin-37 (IL-37) has been identified as a novel anti-inflammatory cytokine which is involved in tumor development. This study aimed to evaluate the expression of IL-37 in serum and determine its clinical significance in human epithelial ovarian cancer (EOC).